Just a moment, the page is loading...

GSK-107876




Study to evaluate clinical consistency of the liquid formulation of GSK Biologicals' HRV vaccine and to evaluate liquid formulation compared to lyophilised formulation of the HRV vaccine administered as a two-dose primary vaccination.
Rotavirus Vaccine
107876
NCT00382772 2006-003239-61
Infections, Rotavirus
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided.
January 2014